173 related articles for article (PubMed ID: 14599705)
1. Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study.
Adunsky A; Chesnin V; Ravona R; Harats D; Davidson M
Arch Gerontol Geriatr; 2004; 38(1):61-8. PubMed ID: 14599705
[TBL] [Abstract][Full Text] [Related]
2. [Achetylcholinesterase (AChE) inhibition and serum lipokines in Alzheimer's disease: friend or foe?].
Kovacs J; Pakaski M; Juhasz A; Feher A; Drotos G; Fazekas CO; Horvath TL; Janka Z; Kalman J
Neuropsychopharmacol Hung; 2012 Mar; 14(1):19-27. PubMed ID: 22427467
[TBL] [Abstract][Full Text] [Related]
3. Donepezil: an update.
Seltzer B
Expert Opin Pharmacother; 2007 May; 8(7):1011-23. PubMed ID: 17472546
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of donepezil: a new treatment of Alzheimer's disease.
Wilkinson DG
Expert Opin Pharmacother; 1999 Nov; 1(1):121-35. PubMed ID: 11249555
[TBL] [Abstract][Full Text] [Related]
5. Donepezil hydrochloride: a treatment drug for Alzheimer's disease.
Sugimoto H
Chem Rec; 2001; 1(1):63-73. PubMed ID: 11893059
[TBL] [Abstract][Full Text] [Related]
6. The effect of donepezil treatment on cardiovascular mortality.
Sato K; Urbano R; Yu C; Yamasaki F; Sato T; Jordan J; Robertson D; Diedrich A
Clin Pharmacol Ther; 2010 Sep; 88(3):335-8. PubMed ID: 20664535
[TBL] [Abstract][Full Text] [Related]
7. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.
Rogers SL; Doody RS; Mohs RC; Friedhoff LT
Arch Intern Med; 1998 May; 158(9):1021-31. PubMed ID: 9588436
[TBL] [Abstract][Full Text] [Related]
8. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
9. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease.
Doody RS; Dunn JK; Clark CM; Farlow M; Foster NL; Liao T; Gonzales N; Lai E; Massman P
Dement Geriatr Cogn Disord; 2001; 12(4):295-300. PubMed ID: 11351141
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.
Homma A; Takeda M; Imai Y; Udaka F; Hasegawa K; Kameyama M; Nishimura T
Dement Geriatr Cogn Disord; 2000; 11(6):299-313. PubMed ID: 11044775
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of therapeutic response to donepezil by positron emission tomography.
Shimada A; Hashimoto H; Kawabe J; Higashiyama S; Kai T; Kataoka K; Tagawa R; Kawarada Y; Nakanishi A; Inoue K; Shiomi S; Kiriike N
Osaka City Med J; 2011 Jun; 57(1):11-9. PubMed ID: 22106763
[TBL] [Abstract][Full Text] [Related]
12. [Interaction of donepezil and muscular blockers in Alzheimer's disease].
Sánchez Morillo J; Demartini Ferrari A; Roca de Togores López A
Rev Esp Anestesiol Reanim; 2003 Feb; 50(2):97-100. PubMed ID: 12712872
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.
Boada-Rovira M; Brodaty H; Cras P; Baloyannis S; Emre M; Zhang R; Bahra R;
Drugs Aging; 2004; 21(1):43-53. PubMed ID: 14715043
[TBL] [Abstract][Full Text] [Related]
14. Clinical benefits of a new piperidine-class AChE inhibitor.
Doody RS
Eur Neuropsychopharmacol; 1999 Apr; 9 Suppl 2():S69-77. PubMed ID: 10332937
[TBL] [Abstract][Full Text] [Related]
15. Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease.
Kim SH; Kandiah N; Hsu JL; Suthisisang C; Udommongkol C; Dash A
Br J Pharmacol; 2017 Dec; 174(23):4224-4232. PubMed ID: 28901528
[TBL] [Abstract][Full Text] [Related]
16. Effect of donepezil in patients with Alzheimer's disease previously untreated or treated with memantine or nootropic agents in Germany: an observational study.
Klinger T; Ibach B; Schoenknecht P; Kamleiter M; Silver G; Schroeder J; Mielke R
Curr Med Res Opin; 2005 May; 21(5):723-32. PubMed ID: 15969871
[TBL] [Abstract][Full Text] [Related]
17. Donepezil effects on hippocampal and prefrontal functional connectivity in Alzheimer's disease: preliminary report.
Zaidel L; Allen G; Cullum CM; Briggs RW; Hynan LS; Weiner MF; McColl R; Gopinath KS; McDonald E; Rubin CD
J Alzheimers Dis; 2012; 31 Suppl 3(0 3):S221-6. PubMed ID: 22886013
[TBL] [Abstract][Full Text] [Related]
18. Cardiac safety of donepezil in elderly patients with Alzheimer disease.
Isik AT; Yildiz GB; Bozoglu E; Yay A; Aydemir E
Intern Med; 2012; 51(6):575-8. PubMed ID: 22449664
[TBL] [Abstract][Full Text] [Related]
19. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
Mizuno S; Kameda A; Inagaki T; Horiguchi J
Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
[TBL] [Abstract][Full Text] [Related]
20. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.
Costa AC; Joaquim HPG; Nunes VS; Kerr DS; Ferreira GS; Forlenza OV; Gattaz WF; Talib LL
Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):501-507. PubMed ID: 28861608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]